Olema Pharmaceuticals, Inc. OLMA 深 滬
等待開盤 10-08 09:30:00 美东时间
8.05
+0.130
+1.64%
華盛通- 最 高8.23
- 今 開7.90
- 成交量 44.63万股
- 最 低 7.79
- 昨 收 7.92
- 總市值 7.04亿
- 52周最高 36.2591
- 市盈率 靜 --
- 換手率 0.51%
- 52周最低 6.65
- 委 比 -67.83%
- 總股本 8749.76万
- 歷史最高 60.27
- 量 比 0.56
- 振 幅 5.56%
- 歷史最低 2.00
- 每 手 1
- 風險率 7.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多
今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元
09-15 15:30
Stifel Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $30
Stifel analyst Laura Prendergast maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $48 to $30.
09-15 02:03
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 500 points on Monday. Shares of Corning Inc (NYSE:GLW) fell sharply in pre-market trading after the company announced a $2 billion offering. Corning shares dipped 8% to $153.05 in pre-market trading. Here are some...
09-14 20:02
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Scholar Rock Holding Corp (NASDAQ:SRRK) rose sharply in pre-market trading after the company announced the FDA approval of ISEMBYLD (apitegromab-mstn), the first and only muscle-targeted treatment for children and adults with Spinal Muscular Atrophy (SMA). Scholar Rock Holding shares jumpe...
09-14 17:50
Olema drops after hours on AstraZeneca Etcamah data
Olema Pharmaceuticals (OLMA), which is developing the estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) palazestrant, is down ~15% in after-hours trading Friday afte...
09-12 06:32
Olema Oncology names Jason O’Byrne as CFO
Olema Pharmaceuticals (OLMA) has appointed Jason O’Byrne as chief financial officer. O’Byrne brings more than two decades of finance and global operations leadership across high-growth biotechnology a...
08-13 21:25
Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer
Olema Pharmaceuticals, Inc. ("Olema Oncology") announced the appointment of Jason O’Byrne, MBA, as Chief Financial Officer. O’Byrne brings over 20 years of finance and global operations leadership in biotech and pharma. He previously served as CFO at Vir Biotechnology and Caribou Biosciences, leading financial and capital markets initiatives, including IPOs and acquisitions. Olema Oncology is advancing therapies for breast cancer, with palazestra...
08-13 11:00
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Citigroup Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $59
Citigroup analyst Yigal Nochomovitz maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $62 to $59.
08-12 03:28
OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.1% on Tuesday. Shares of OppFi Inc (NYSE:OPFI) fell sharply in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates. OppFi ...
08-11 20:04
